Table 3 Treatment delivery
SP (n = 159) | Non-SP (n = 157) | χ2 test P-value | |
|---|---|---|---|
Chemotherapy | |||
1 | 14 | 4 | |
2 | 18 | 17 | |
3 | 6 | 12 | |
4 | 121 (76.1%) | 124 (78.9%) | |
RT | |||
< 40 Gy | 4 | 0 | |
40–59 Gy | 3 | 4 | |
60 Gy | 152 (95.5%) | 153 (97.4%) | |
Median (range) | 60 (16–60) | 60 (40–60) | |
Completed RT within 56 days | 149 (93.7%) | 150 (95.5%) | |
More than 2 courses of chemotherapy | 145 | 153 | |
Dose reduction | 26 (17.9%) | 42 (27.4%) | 0.049 |
Delayed course | 114(78.6%) | 97(63.4%) | 0.005 |
Relapse | 108 | 110 | |
Subsequent therapy following relapse | 100 (92.5%) | 89 (80.9%) | 0.010 |